V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 170011451 | 170004604 | null | null | 03 | null | 2021-03-03 | ABEMACICLIB + FULVESTRANT | 02 | N | CYTARABINE | 100160341 |
| 170011469 | 170004606 | null | null | Curative (C) | null | 2018-06-25 | Eribulin | 2 | N | BEVACIZUMAB | 100811473 |
| 170011770 | 170004611 | 1.96 | 85 | null | null | 2018-09-25 | PEMBROLIZUMAB | null | null | ENZALUTAMIDE | 101175925 |
| 170012101 | 170004615 | null | 54.5 | null | null | 2019-04-16 | Eribulin | null | null | CISPLATIN + GEMCITABINE | 100540494 |
| 170012175 | 170004617 | null | null | null | null | 2021-11-13 | null | 02 | null | LENALIDOMIDE | 101596575 |
| 170012176 | 170004618 | null | 64.2 | Palliative (P) | null | 2021-11-03 | null | N | N | TRASTUZUMAB | 101809930 |
| 170012208 | 170004619 | 1.61 | null | null | null | 2017-10-26 | null | null | null | RALTITREXED | 100665261 |
| 170012221 | 170004620 | 1.54 | 63.8 | null | null | 2020-08-29 | null | null | null | GEMCITABINE + NAB-PACLITAXEL | 100713280 |
| 170012459 | 170004622 | null | null | null | 2021-06-09 | 2021-07-17 | BLEOMYCIN + CISPLATIN + ETOPOSIDE + PACLITAXEL | 02 | null | CISPLATIN + CYCLOPHOSPHAMIDE + DOXORUBICIN + ETOPOSIDE + THALIDOMIDE | 100987358 |
| 170012728 | 170004624 | 1.57 | 0 | null | null | 2021-01-05 | null | null | null | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 101823653 |
| 170012760 | 170004625 | null | 64.7 | Adjuvant (A) | null | 2016-05-11 | FLUDARABINE | null | N | CONFIRM TRIAL | 101200643 |
| 170013154 | 170004629 | 1.65 | 65.7 | Palliative (P) | null | 2022-02-18 | Docetaxel 100mg/m2 (21 day) | 02 | N | METHOTREXATE | 101865690 |
| 170013366 | 170004630 | null | null | null | 2017-12-28 | 2018-07-13 | LENALIDOMIDE + dexamethasone. | null | null | BEVACIZUMAB | 101789616 |
| 170014898 | 170004639 | 1.57 | 73.1 | null | null | 2021-01-29 | Bevacizumab 7.5mg/kg | null | null | NIVOLUMAB | 101360144 |
| 170015763 | 170004642 | null | null | Neo-adjuvant (N) | null | 2019-07-14 | CAPECITABINE + TEMOZOLOMIDE | 01 | N | PACLITAXEL | 101701349 |
| 170016039 | 170004644 | null | null | null | null | 2020-05-10 | Nelarabine | null | null | BORTEZOMIB + MELPHALAN | 100748907 |
| 170016380 | 170004648 | null | null | Palliative (P) | null | 2022-02-08 | CISPLATIN + GEMCITABINE | N | N | BEVACIZUMAB | 100214969 |
| 170016509 | 170004649 | null | 78 | null | null | 2018-03-06 | Epirubicin (weekly) | null | null | LENALIDOMIDE | 101515136 |
| 170017097 | 170004652 | null | null | null | 2020-11-16 | 2020-11-23 | Docetaxel | null | null | BORTEZOMIB + THALIDOMIDE | 100196259 |
| 170001573 | 170004657 | null | null | null | null | 2021-03-29 | Capecitabine | null | null | IBRUTINIB | 100917424 |
| 170001935 | 170004658 | null | null | null | null | 2018-01-27 | Paclitaxel 7 day | null | null | MELPHALAN | 101215867 |
| 170003083 | 170004659 | null | null | null | null | 2020-12-08 | Docetaxel + nintedanib | null | null | DURVALUMAB | 100622059 |
| 170006101 | 170004663 | null | null | null | null | 2018-01-26 | PEMBROLIZUMAB | 02 | null | IMATINIB | 101626727 |
| 170010648 | 170004665 | null | null | null | null | 2016-12-11 | Abiraterone | 02 | null | NIVOLUMAB | 101050966 |
| 170000068 | 170004671 | 1.53 | null | null | null | 2018-02-16 | MELPHALAN | null | null | PERTUZUMAB + TRASTUZUMAB | 100233968 |
| 170000506 | 170004673 | null | 131.7 | null | null | 2022-03-06 | Docetaxel | null | null | BEVACIZUMAB | 101829264 |
| 170002132 | 170004677 | null | 88 | null | null | 2021-04-18 | Paclitaxel 7 day | null | null | TRANSPLANT MELPHALAN AUTOLOGOUS | 101450956 |
| 170003397 | 170004682 | 0 | 70 | null | 2021-07-22 | 2021-07-23 | Enzalutamide | 02 | null | CISPLATIN + VINORELBINE | 101637855 |
| 170004271 | 170004683 | null | null | null | 2016-12-17 | 2016-12-27 | CLOFARABINE + CYCLOPHOSPHAMIDE + ETOPOSIDE | null | null | HYDROXYCARBAMIDE | 100467435 |
| 170004319 | 170004685 | 1.76 | 55 | null | null | 2017-08-31 | null | 02 | null | CABAZITAXEL | 100958696 |
| 170004411 | 170004687 | null | 125.9 | null | null | 2020-10-24 | Bendamustine + Obinutuzumab | null | null | TEMOZOLOMIDE | 101341676 |
| 170004723 | 170004689 | 1.65 | 58.3 | Disease modification (D) | 2021-02-15 | 2021-02-21 | null | null | N | CNS LGG2004 03 VINC + CARBO | 100539150 |
| 170005068 | 170004691 | null | 98.5 | null | 2021-09-12 | 2021-09-12 | CAPECITABINE + RT | null | null | LENALIDOMIDE | 100711846 |
| 170005263 | 170004692 | null | 69.1 | Palliative (P) | null | 2021-07-24 | null | 02 | N | FLUOROURACIL + OXALIPLATIN | 100560960 |
| 170005327 | 170004693 | 1.85 | 34.45 | Palliative (P) | 2019-08-13 | 2020-07-29 | Enzalutamide | 02 | N | IRINOTECAN | 101480706 |
| 170005745 | 170004694 | null | null | Neo-adjuvant (N) | 2022-03-17 | 2022-03-17 | null | 02 | N | LORLATINIB | 100286593 |
| 170006456 | 170004698 | 1.64 | 91 | Adjuvant (A) | null | 2022-02-10 | null | 2 | N | LENALIDOMIDE | 101266450 |
| 170008307 | 170004707 | null | null | null | null | 2020-03-26 | null | 2 | null | TRIAL UNSPECIFIED | 100887444 |
| 170008559 | 170004708 | null | null | 03 | 2021-08-09 | 2021-08-09 | null | 01 | N | PACLITAXEL | 100161387 |
| 170008860 | 170004711 | 1.59 | 65.7 | null | 2020-03-04 | 2020-07-28 | null | null | null | EPIRUBICIN | 101678149 |
| 170009054 | 170004712 | 1.49 | 65.1 | Curative (C) | null | 2022-02-24 | IBRUTINIB | 02 | N | CNS LGG 2004 03 VINC WEEKLY+ CARBO | 101446088 |
| 170009227 | 170004713 | null | null | null | null | 2017-01-20 | null | 02 | null | CARBOPLATIN + VINORELBINE | 100689484 |
| 170010985 | 170004718 | null | null | null | 2020-08-30 | 2021-02-20 | Ixazomib + Lenalidomide | 02 | null | CAPECITABINE | 100693504 |
| 170011034 | 170004719 | 1.52 | 56.4 | null | null | 2022-01-14 | Capecitabine | null | null | DOXORUBICIN + IFOSFAMIDE | 101517161 |
| 170011526 | 170004722 | null | null | 03 | null | 2021-09-12 | Alectinib | 02 | N | CAPECITABINE | 100930517 |
| 170012722 | 170004730 | null | null | Curative (C) | null | 2021-05-24 | null | 02 | N | CAPECITABINE | 100500674 |
| 170013078 | 170004731 | null | null | null | 2020-06-24 | 2020-08-01 | null | 02 | null | BEVACIZUMAB | 100326207 |
| 170013124 | 170004732 | null | null | null | null | 2020-01-31 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | null | null | DARATUMUMAB | 100456412 |
| 170013154 | 170004733 | null | null | 03 | null | 2022-02-18 | null | 02 | N | LENALIDOMIDE | 101865690 |
| 170014523 | 170004739 | 1.84 | 87.4 | null | 2020-06-09 | 2022-01-23 | PACLITAXEL | null | null | CAPECITABINE | 100161926 |